Sex: F
Vaccine: RAB
Symptoms: Exposure to communicable disease, Incomplete course of vaccination, Product dose omission issue
Clinical narrative: The patient got part of the post-exposure prophylaxis series at the beginning of May, missed a dose of the first series, did not get the fourth RabAvert dose; Case reference number US-BN-2023-001029 is a spontaneous case report initially received from a physician via Company (reference number: USBAV23-0775) on 19-Jun-2023 and concerns a female patient of unknown age.  The patient's relevant medical history and concomitant medication details were not provided.  On an unspecified date, the patient had an exposure. On the same day, reported as on day zero and as at the beginning of May of unspecified year, the patient was vaccinated with the first dose of RabAvert (batch number not provided) at an unknown dose, route or site of administration for rabies post-exposure prophylaxis (PEP).  On an unspecified date, an unknown amount of time after the exposure, reported as on day three and as at the beginning of May of unspecified year, the patient was vaccinated with the second dose or RabAvert (batch number not provided) at an unknown dose, route or site of administration.  On an unspecified date, an unknown amount of time after the exposure, reported as on day seven and as at the beginning of May of unspecified year, the patient was vaccinated with the third dose or RabAvert (batch number not provided) at an unknown dose, route or site of administration.  As reported, the patient got part of the PEP series, missed a dose of the first series, did not get the fourth RabAvert dose (explicitly coded as 'incomplete course of vaccination').  On an unspecified date, the patient had another exposure.   On an unspecified date, an unknown amount of time after another exposure, the patient received the first dose of RabAvert (batch number not provided) at an unknown dose, route or site of administration for rabies PEP.  As reported, the physician guessed the emergency room (ER) gave the patient one dose but the patient did not get anymore after that.  On an unspecified date, reported as today, unspecified amount of time after another exposure, the patient would come in for the second RabAvert dose.  At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert.  Additional information received from Bavarian Nordic on 20-Jun-2023 included local BN case ID.; Reporter's Comments: A female patient of unknown age was vaccinated with three doses of RabAvert vaccine for rabies post-exposure prophylaxis and reportedly did not get the fourth dose, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to RabAvert, but to a human factor. The case is non-serious.; Sender's Comments: A female patient of unknown age was vaccinated with three doses of RabAvert vaccine for rabies post-exposure prophylaxis and reportedly did not get the fourth dose, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to RabAvert, but to a human factor. The case is non-serious.